BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23021567)

  • 1. Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence.
    Corominas-Roso M; Roncero C; Eiroa-Orosa FJ; Gonzalvo B; Grau-Lopez L; Ribases M; Rodriguez-Cintas L; Sánchez-Mora C; Ramos-Quiroga JA; Casas M
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1078-84. PubMed ID: 23021567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum brain-derived neurotrophic factor levels and cocaine-induced transient psychotic symptoms.
    Corominas-Roso M; Roncero C; Eiroa-Orosa FJ; Ribasés M; Barral C; Daigre C; Martínez-Luna N; Sánchez-Mora C; Ramos-Quiroga JA; Casas M
    Neuropsychobiology; 2013; 68(3):146-55. PubMed ID: 24051573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in brain-derived neurotrophic factor (BDNF) during abstinence could be associated with relapse in cocaine-dependent patients.
    Corominas-Roso M; Roncero C; Daigre C; Grau-Lopez L; Ros-Cucurull E; Rodríguez-Cintas L; Sanchez-Mora C; Lopez MV; Ribases M; Casas M
    Psychiatry Res; 2015 Feb; 225(3):309-14. PubMed ID: 25592977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal.
    Costa MA; Girard M; Dalmay F; Malauzat D
    Alcohol Clin Exp Res; 2011 Nov; 35(11):1966-73. PubMed ID: 21848960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in brain-derived neurotrophic factor expression in early crack cocaine withdrawal.
    von Diemen L; Kapczinski F; Sordi AO; de Magalhães Narvaez JC; Guimarães LS; Kessler FH; Pfaffenseller B; de Aguiar BW; de Moura Gubert C; Pechansky F
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):33-40. PubMed ID: 24067327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal.
    Huang MC; Chen CH; Chen CH; Liu SC; Ho CJ; Shen WW; Leu SJ
    Alcohol Alcohol; 2008; 43(3):241-5. PubMed ID: 18326550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum brain-derived neurotrophic factor levels during opiate withdrawal.
    Zhang J; Zhang X; Su H; Tao J; Xie Y; Han B; Lu Y; Wei Y; Sun H; Wang Y; Wu W; Zou S; Liang H; Zoghbi AW; Tang W; He J
    Neurosci Lett; 2014 Jun; 571():61-5. PubMed ID: 24810885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor serum levels in heroin-dependent patients after 26weeks of withdrawal.
    Zhang K; Jiang H; Zhang Q; Du J; Wang Y; Zhao M
    Compr Psychiatry; 2016 Feb; 65():150-5. PubMed ID: 26774004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal.
    Heberlein A; Muschler M; Wilhelm J; Frieling H; Lenz B; Gröschl M; Kornhuber J; Bleich S; Hillemacher T
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1060-4. PubMed ID: 20553781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of BDNF are associated with craving in opiate-dependent patients.
    Heberlein A; Dürsteler-MacFarland KM; Lenz B; Frieling H; Grösch M; Bönsch D; Kornhuber J; Wiesbeck GA; Bleich S; Hillemacher T
    J Psychopharmacol; 2011 Nov; 25(11):1480-4. PubMed ID: 21890593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum brain-derived neurotrophic factor is predictive of cocaine relapse outcomes: a prospective study.
    D'Sa C; Fox HC; Hong AK; Dileone RJ; Sinha R
    Biol Psychiatry; 2011 Oct; 70(8):706-711. PubMed ID: 21741029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of testosterone and BDNF serum levels with craving during alcohol withdrawal.
    Heberlein A; Lenz B; Opfermann B; Gröschl M; Janke E; Stange K; Groh A; Kornhuber J; Frieling H; Bleich S; Hillemacher T
    Alcohol; 2016 Aug; 54():67-72. PubMed ID: 27514572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor.
    Angelucci F; Ricci V; Pomponi M; Conte G; Mathé AA; Attilio Tonali P; Bria P
    J Psychopharmacol; 2007 Nov; 21(8):820-5. PubMed ID: 17715210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of brain-derived neurotrophic factor are associated with treatment adherence among crack-cocaine users.
    Scherer JN; Schuch S; Ornell F; Sordi AO; Bristot G; Pfaffenseller B; Kapczinski F; Kessler FHP; Fumagalli F; Pechansky F; von Diemen L
    Neurosci Lett; 2016 Sep; 630():169-175. PubMed ID: 27473943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DHEAS and POMS measures identify cocaine dependence treatment outcome.
    Wilkins JN; Majewska MD; Van Gorp W; Li SH; Hinken C; Plotkin D; Setoda D
    Psychoneuroendocrinology; 2005 Jan; 30(1):18-28. PubMed ID: 15358439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety.
    Molendijk ML; Bus BA; Spinhoven P; Penninx BW; Prickaerts J; Oude Voshaar RC; Elzinga BM
    World J Biol Psychiatry; 2012 Oct; 13(7):535-43. PubMed ID: 21888560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats.
    Berglind WJ; See RE; Fuchs RA; Ghee SM; Whitfield TW; Miller SW; McGinty JF
    Eur J Neurosci; 2007 Aug; 26(3):757-66. PubMed ID: 17651427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity.
    Pedraz M; Martín-Velasco AI; García-Marchena N; Araos P; Serrano A; Romero-Sanchiz P; Suárez J; Castilla-Ortega E; Barrios V; Campos-Cloute R; Ruiz JJ; Torrens M; Chowen JA; Argente J; de la Torre R; Santín LJ; Villanúa MÁ; Rodríguez de Fonseca F; Pavón FJ
    PLoS One; 2015; 10(3):e0118610. PubMed ID: 25734326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of oxidative stress and brain-derived neurotrophic factor levels related to crack-use detoxification.
    Hirsch GE; Jaskulski M; Hamerski HM; Porto FG; da Silva B; Aita CAM; Kroker K; de Bem Silveira G; Silveira PCL; Santos GT; Klafke JZ; Viecili PRN
    Neurosci Lett; 2018 Mar; 670():62-68. PubMed ID: 29374540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-Dependent Serum Brain-Derived Neurotrophic Factor Decline During Methamphetamine Withdrawal.
    Ren W; Tao J; Wei Y; Su H; Zhang J; Xie Y; Guo J; Zhang X; Zhang H; He J
    Medicine (Baltimore); 2016 Feb; 95(5):e2604. PubMed ID: 26844469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.